首页 | 本学科首页   官方微博 | 高级检索  
     

GnRHa用于化疗后生育力保护的循证医学研究进展
引用本文:赵全凤,符佩姝,谷文睿,郑丹,吕宗杰,杨洋.GnRHa用于化疗后生育力保护的循证医学研究进展[J].金属学报,2021,26(12):1449-1454.
作者姓名:赵全凤  符佩姝  谷文睿  郑丹  吕宗杰  杨洋
作者单位:1.陆军军医大学第一附属医院药学部,重庆 400038;2重庆市妇幼保健院药剂科,重庆 401147
基金项目:重庆市技术创新与应用发展专项面上项目(cstc2019jscx-msxmX0096)
摘    要:随着肿瘤患者长期生存率提高,年轻肿瘤患者化疗后生育力保护的要求日益凸显。早期研究显示促性腺激素释放激素激动剂(GnRHa)具有一定的生育力保护作用,但近年来相关研究显示其保护作用存在争议。本文综述GnRHa用于常见肿瘤患者生育力保护的临床研究,挖掘其循证医学证据,以期为临床合理用药提供参考。

关 键 词:促性腺激素释放激素激动剂  生育力保护  化疗  循证医学  
收稿时间:2021-03-30
修稿时间:2021-09-21

Advances in evidence-based medical research of GnRHa for fertility protection after chemotherapy
ZHAO Quanfeng,FU Peishu,GU Wenrui,ZHEN Dan,LV Zongjie,YANG Yang.Advances in evidence-based medical research of GnRHa for fertility protection after chemotherapy[J].Acta Metallurgica Sinica,2021,26(12):1449-1454.
Authors:ZHAO Quanfeng  FU Peishu  GU Wenrui  ZHEN Dan  LV Zongjie  YANG Yang
Affiliation:1.Department of Pharmacy, Southwest Hospital, First Affiliated Hospital to Third Military Medical University (Army Medical University), Chongqing 400038, China;2.Department of Pharmacy, Chongqing Health Center for Women and Children, Chongqing 401147, China
Abstract:With an improvement in the long-term survival rates of cancer patients, the requirements for fertility protection of young cancer patients after chemotherapy are increasingly prominent. Early studies have shown that gonadotropin-releasing hormone agonist (GnRHa) has a protective effect on fertility. But in recenct year, relevant studies have shown that its protective effect is controversial. This article reviews the clinical researches of GnRHa for fertility protection in patients with common tumors, and explores its evidence-based medicine, in the hope of providing references for reasonable clinical application.
Keywords:gonadotropin-releasing hormone agonists (GnRHa)     fertility protection  chemotherapy  evidence-based medicine  
点击此处可从《金属学报》浏览原始摘要信息
点击此处可从《金属学报》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号